These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 16368045

  • 1. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial.
    Innocenzi D, Lupi F, Bruni F, Frasca M, Panetta C, Milani M.
    Curr Med Res Opin; 2005 Dec; 21(12):1949-53. PubMed ID: 16368045
    [Abstract] [Full Text] [Related]

  • 2. An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis.
    Innocenzi D, Ruggero A, Francesconi L, Lacarrubba F, Nardone B, Micali G.
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S27-30. PubMed ID: 18727813
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A, Iorizzo M, Botta GL, Milani M.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [Abstract] [Full Text] [Related]

  • 4. An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.
    Flanagan KH, Glaser DA.
    J Drugs Dermatol; 2009 May; 8(5):477-80. PubMed ID: 19537371
    [Abstract] [Full Text] [Related]

  • 5. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M, Plewig G, Hyperhidrosis Study Group.
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
    Bechara FG, Gambichler T, Bader A, Sand M, Altmeyer P, Hoffmann K.
    J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
    [Abstract] [Full Text] [Related]

  • 8. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis.
    Wollina U, Köstler E, Schönlebe J, Haroske G.
    Dermatol Surg; 2008 May; 34(5):709-16. PubMed ID: 18318727
    [Abstract] [Full Text] [Related]

  • 9. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial.
    Vena GA, Cassano N, D'Argento V, Milani M.
    Br J Dermatol; 2006 Feb; 154(2):353-6. PubMed ID: 16433809
    [Abstract] [Full Text] [Related]

  • 10. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H, Briand N, Bara C, Celerier P.
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [Abstract] [Full Text] [Related]

  • 12. Current therapeutic strategies for hyperhidrosis: a review.
    Togel B, Greve B, Raulin C.
    Eur J Dermatol; 2002 May; 12(3):219-23. PubMed ID: 11978559
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.
    Flanagan KH, King R, Glaser DA.
    J Drugs Dermatol; 2008 Mar; 7(3):221-7. PubMed ID: 18380203
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
    Baumgartner FJ, Bertin S, Konecny J.
    Ann Vasc Surg; 2009 Mar; 23(1):1-7. PubMed ID: 18619780
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 18. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients.
    Lawrence CM, Lonsdale Eccles AA.
    Br J Dermatol; 2006 Jul; 155(1):115-8. PubMed ID: 16792762
    [Abstract] [Full Text] [Related]

  • 19. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis.
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [Abstract] [Full Text] [Related]

  • 20. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
    Davarian S, Kalantari KK, Rezasoltani A, Rahimi A.
    Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.